TBC1D20 Antibodies

Santa Cruz Biotechnology delivers a wide array of TBC1D20 monoclonal antibodies for research focused on understanding TBC1D20's role in cellular processes. TBC1D20 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TBC1D20 belongs to the TBC (Tre-2/Bub2/CDC16) domain family, which regulates Rab GTPase activity and plays a crucial role in vesicle trafficking and cellular signaling. TBC1D20 maintains cellular homeostasis and influences various physiological processes, including metabolism and immune response. Research has shown that TBC1D20 dysfunction can lead to several pathological conditions. Understanding TBC1D20's molecular mechanisms and interactions provides valuable insights into potential therapeutic strategies. Investigating TBC1D20's role in cellular pathways can reveal new perspectives in disease treatment and prevention. Recent studies have highlighted TBC1D20's significance in maintaining cellular function and regulation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TBC1D20's role in health and disease.